[1] ZHANG Xianzhong. Study and Application of New Technetium-99m Labeled ISO Nitrile Complexes[D]. Beijing:Beijing Normal University, 2002(5):8. (in Chinese) (张现忠. 新型锝-99m标记异腈类配合物的研究及其应用[D]. 北京:北京师范大学, 2002(5):8.)
[2] XIAO Fu. Technetium-the main force in clinical nuclear medicine diagnosis. Guangdong:Radiation Protection Association of Guangdong Province[EB/OL]. 2016-06-01. http://www.gdfushefanghuxiehui.com/menberview.asp?id=2&viewid=703. (in Chinese) (小辐. 锝——临床核医学诊断中的主力军[EB/OL]. 2016-06-01. 广东省:广东辐射防护协会. http://www.gdfushefanghuxiehui.com/menberview.asp?id=2&viewid=703
[3] SOUTO F J, KIMPLAND R H, HEGER A S. Prenatal Diagnosis, 2005, 33(6):575.
[4] ZHANG Yan. Foreign Nuclear News, 2011(6):28. (in Chinese) (张焰. 国外核新闻, 2011(6):28.)
[5] AHMAD M, VANDEGRIFT G, CRISTINI P. Science & Technology of Nuclear Installations, 2013, 1:3.
[6] WU Haosong. Foreign Nuclear News, 2016(12):16. (in Chinese) (伍浩松. 国外核新闻, 2016(12):16.)
[7] LYRA M, CHARALAMBATOU P, ROUSSOU E, et al. Hellenic Journal of Nuclear Medicine, 2011, 14(1):49.
[8] GAO Feng, LIN Li, LIU Yuhao, et al. Journal of Isotopes, 2012, 21(6):257. (in Chinese) (高峰, 林力, 刘宇昊, 等. 同位素, 2012, 21(6):257.)
[9] WU Haosong. Foreign Nuclear News, 2011(6):28. (in Chinese) (伍浩松. 国外核新闻, 2011(6):28.)
[10] LI Mingqi, DENG Qimin, CHENG Zuoyong, et al. Journal of Isotopes, 2013, 26(3):186. (in Chinese) (李明起, 邓启民, 程作用, 等. 同位素, 2013, 26(3):186.)
[11] PONSARD B. Kernkraftwerke in Deutschland Betriebsergebnisse, 2015, 61(1):41.
[12] ZOU Wei, YIN Hongyu, LIU Qiong. Chinese Journal of Nuclear Medicine and Molecular Imaging, 2016, 36(4):375. (in Chinese) (邹巍, 尹红玉, 刘琼. 中华核医学与分子影像杂志, 2016, 36(4):375.)
[13] FILZEN M, ELLINGSON R, PAULSEN M, et al. Journal of Nuclear Medicine Technology, 2017, 45:1.
[14] Non-HEU Production technologies for molybdenum-99 and technetium-99m[M]. Vienna:IAEA Nuclear Energy Series No.NF-T-5.4. ISBN 978-92-0-137710-4.
[15] Opportunities and Approaches for Supplying Molybdenum-99 and Associated Medical Isotopes to Global Markets:Proceedings of a Symposium[C]. National Academies of Sciences, Engineering, and Medicine 2018 Washington, DC. The National Academies Press.
[16] RYABCHIKOV A I, SKURIDIN V S, NESTEROV E V, et al. Nucl Instr and Meth B, 2004, 213(03):364.
[17] KNAPP F, MIZADEH S. Europe Journal of Nuclear Medical 1994, 21(10):1151.
[18] The Supply of Medical Radioisotopes:Review of Potential Molybdenum-99/Technetium-99m Production Technologies[M]. Vienna:Nuclear Energy Agency.2010. ISBN:978-92-64-99164-4.
[19] ZYKOV M, ROMANOVSKⅡ N, WESTER D, et al. Radiochemistry, 2001, 43(3):297.
[20] BALL R. Medical Isotope Production Reactor[P]. US:5596611,1997.01.21.
[21] VALENTIN I. Research Reactors in Russia:Status and Prospects for Reducing the Fuel Enrichment, 2010.
[22] PAVSHOOK V, KHVOSTIONOV V. International Meeting on Reduced Enrichment for Research and Test Reactors. October 18-23, 1998.
[23] CHUVILIN D, KHVOSTIONOV V, MARKOVSKIJ D, et al. Applied Radiation and Isotopes, 2007, 65(10):1087.
[24] Homogeneous Aqueous Solution Nuclear Reactors for the Production of Mo-99 and Other Short-lived Radioisotopes[M]. IAEA-TECDOC-1601, Vienna, Austria, September 2008 ISBN:978-92-0-109708-8.
[25] LI Yunzhao, WU Hongchun, CAO Liangzhi, et al. Nuclear Power Engineering, 2009, 30(6):15.
[26] DENG Qimin, LI Maoliang, CHENG Zuoyong. Chinese Journal of Nuclear Science and Engineering, 2006, 26(2):165. (in Chinese). (邓启民, 李茂良, 程作用. 核科学与工程, 2006, 26(2):165.)
[27] CHABOD S, BLANDIN C, CHARTIER F, et al. Nucl Instr and Meth A. 2006, 562(2):618.
[28] PANEBIANCO S, BEAUVAIS P, BRINGER O, et al. International Conference on Nuclear Data for Science and Technology 2007.
[29] GREG C. Argonne National Laboratory. 2015.06.15.
[30] CHEMERISOV S, YOUKER A, HEBDEN A, et al. Mo-99 topical meeting, December 4-7, 2011, New Mexico.
[31] YOUKER A, CHEMERISOV S, TKAC P. Mo-99 Topical Meeting on Molybdenum-99 Technological Development, September 11-14, 2016, St. Louis, Missouri.
[32] WU Yican. International Journal of Energy Research, 2017, 42:3572.
[33] WU Yican, LIU Chao, SONG Gang, et al. Nuclear Science and Engineering, 2016, 36(1):77. (in Chinese) (吴宜灿, 刘超, 宋钢, 等. 核科学与工程, 2016, 36(1):77.
[34] TKAC P, CHEMERISOV S, MAKARASHVILI V, et al. Mo-992013 Topical Meeting on Molybdenum-99 Technological Development. April 1-5, 2013, Chicago, Illinois.
[35] FONG A, MEYER T, ZALA K. Task Force on Alternatives for Medical Isotope, October 19-20, 2008, Vancouver.
[36] BUNATIAN G, NIKOLENKO V, POPOV A. Eprint arXiv:1012.5002, 2009.
[37] BENNETT R, CHRISTIAN J, PETTI D, et al. Nuclear Technology, 1999, 126(1):102.
[38] RICHARD V. Nature, 2013, 504(7479):202.
[39] DALE G, CHEMERISOV S, VANDEGRIFT G, et al. AIP Conference Proceedings. American Institute of Physics, 2013:355.
[40] WOLOSHUN K, DALE G, KELSEY C. 5th High Power Targetry Workshop, 2013(01):41.
[41] SCHOLTEN B, LAMBRECHT R, COGNEAU M, et al. Applied Radiation and Isotopes, 1999, 51(1):69.
[42] TAKACS S, SZUCS Z, TARKANYI F, et al. Journal of Radioanalytical and Nuclear Chemistry. 2003, 257(1):195.
[43] GUERIN B, SEBASTIEN T, RODRIGUE S, et al. Journal of Nuclear Medicine, 2010, 51(4):13N.
[44] Medical Isotope Production Without Highly Enriched Uranium[M]. Washington DC:National Academies Press, 2009.
[45] SCHAFFER P, BENARD F, BERNSTEIN A, et al. Physics Procedia. 2015(66):383.
[46] Nuclear Technology Review[M]. International Atomic Energy Agency, 2010, Vienna, Austria.
[47] National Research Council (US) Committee on Medical Isotope Production Without Highly Enriched Uranium. Nonproliferation Review, 2009, 16(2):285.
[48] XU Xiaofei, MA Hongli. Science & Technology Vision, 2014(22):8. (in Chinese) (许晓飞, 马红利. 科技视界, 2014(22):8.)
[49] WALT T, COETZEE P. Radiochimical Acta/International Journal for Chemical Aspects of Nuclear Science & Technology, 2004, 92(4-6/2004):251.
[50] WU D, LANDSBERGER S, VANDEGRIFT G. Office of Scientific & Technical Information Technical Reports, 1996.
[51] HWANG D, CHOUNG W, KIM Y, et al. Journal of Radioanalytical & Nuclear Chemistry, 2002, 254(2):255.
[52] WANG Qinggui, LIANG Jixin, WU Yuxuan. Journal of Isotopes, 2016, 29(4):216. (in Chinese) (王清贵, 梁积新, 吴宇轩. 同位素, 2016, 29(4):216.)
[53] CHEMERISOV S, YOUKER A, HEBDEN, et al. Molybdenum-99 Topical Meeting. New Mexico December 4-7, 2011 La Fonda Hotel Santa Fe.
[54] YOUKER A, CHEMERISOV S, TKAC P, et al. Journal of Nuclear Medicine Official Publication Society of Nuclear Medicine, 2016, 58(3):514.
[55] YOUKER A, CHEMERISOV S, TKAC P. Mo-992016 Topical Meeting on Molybdenum-99 Technological Development. Sep11-14, 2016 St. Louis, Missouri.
[56] MARTINI P, BOSCHI A, CICORIA G, et al. Applied Radiation and Isotopes, 2016, 118:302.
[57] BOSCHI A, MARTINI P, PASQUALI M, et al. Drug Development and Industrial Pharmacy, 2017:1.
[58] WU haosong. Foreign Nuclear News, 2016(4):1. (in Chinese) (伍浩松. 国外核新闻, 2016(4):1.)